Last reviewed · How we verify
Uptravi® Film Coated Tablets
Uptravi® Film Coated Tablets is a Small molecule drug developed by Humanis Saglık Anonim Sirketi. It is currently in Phase 1 development.
At a glance
| Generic name | Uptravi® Film Coated Tablets |
|---|---|
| Sponsor | Humanis Saglık Anonim Sirketi |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Uptravi® Film Coated Tablets CI brief — competitive landscape report
- Uptravi® Film Coated Tablets updates RSS · CI watch RSS
- Humanis Saglık Anonim Sirketi portfolio CI
Frequently asked questions about Uptravi® Film Coated Tablets
What is Uptravi® Film Coated Tablets?
Uptravi® Film Coated Tablets is a Small molecule drug developed by Humanis Saglık Anonim Sirketi.
Who makes Uptravi® Film Coated Tablets?
Uptravi® Film Coated Tablets is developed by Humanis Saglık Anonim Sirketi (see full Humanis Saglık Anonim Sirketi pipeline at /company/humanis-sagl-k-anonim-sirketi).
What development phase is Uptravi® Film Coated Tablets in?
Uptravi® Film Coated Tablets is in Phase 1.